The paper's own title carries the step the press summary leaves implicit. It names infection-induced glucose starvation as the trigger for NINJ1-dependent macrophage lysis and Candida escape [7]. Put in order, that is a fuel fight inside one cell: the macrophage swallows the fungus, the fungus fights back from within, NINJ1 assembles large pores, and the immune cell ruptures and scatters live fungal cells [5]. Alanine is a naturally occurring amino acid, and the Nature Communications study reports that it reverses that process [19]. The plausible reading is that alanine hands the host cell a substrate it can burn while the fungus is taking the glucose, so the starvation signal that summons NINJ1 never arrives. The published account does not spell that out, and it gives no concentration, no named cell type, and no statement about whether anything was dosed in an animal [17].
That is the distance between a mechanism and a medicine. A higher dose of alanine in a dish is a lab condition, not a diet [6], and nothing here says a patient who consumes more alanine keeps their macrophages whole.
The scale of what is at stake is large. The two species are together credited with almost a million deaths worldwide each year [1], which works out near 2,700 a day [15]. Growing outbreaks in Europe and the United States have already forced restrictions and even closures of intensive care units, while the fungi remain relatively uncommon in Australia [3]. Professor Ana Traven, senior author on both papers [18], attributes part of the pressure to changing climate conditions [13].
The second paper works the other end of the same nutrient axis. Irma Tedja, its first author, describes Candida auris as an environmental sensor that monitors which sugars are available in human tissue and alters its cell shape and properties accordingly [11]. That work appears in Nature Microbiology [16].
What this pair leaves open is how much of either signal is load-bearing in a body rather than a well. What it does establish is a target with a name, on the host side of the fight, where the readout is whether a cell stays intact. That is an unusually clean thing to test next, and it is also the kind of result that reads better in a summary than it will in a first animal study, because the concentration that holds a pore shut in culture has no announced equivalent in blood [17]. Weerasinghe's own framing is modest about it: the win is a cellular bottleneck that holds the pathogen where something else can kill it [8].
